52‐4: A Four‐Way Viewing Angle Controllable Liquid Crystal Display Technology with Dual Cell Design
SID Symposium Digest of Technical Papers · 2026-08 · 57 (S1) · 524-526
DOI: 10.1002/sdtp.70003_135 ↗Kurz gefasst
Fachartikel in der Zeitschrift SID Symposium Digest of Technical Papers, online erschienen am 11.09.2026. Verfasst von Tao Liu und 6 weiteren Autor:innen. Die Arbeit nennt 3 Literaturangaben.
Abstract (Originalsprache)
In this paper, we proposed a four‐way viewing angle controllable liquid crystal display structure with dual cell design. The viewing angle controllable cell with FFS electrode structure is used to realize the wide viewing angle in the horizontal and vertical direction, which can effectively control the light path by voltage setting. Besides, the four‐way narrow viewing angle is achieved under the effect of the light control system. The actual optical results show the luminance ratio between 45deg. and 0deg. is about 3.0% in the sharing mode and 0.3% in the privacy mode. Finally, excellent display performance is achieved at both wide and narrow viewing angles.
Zitieren
APA
Liu, T., Liu, X., Zhang, X., Jiang, J., Zheng, H., Liao, P., & Chung, S. (2026). 52‐4: A Four‐Way Viewing Angle Controllable Liquid Crystal Display Technology with Dual Cell Design. SID Symposium Digest of Technical Papers, 57(S1), 524-526. https://doi.org/10.1002/sdtp.70003_135
Vancouver
Liu T, Liu X, Zhang X, Jiang J, Zheng H, Liao P, et al. 52‐4: A Four‐Way Viewing Angle Controllable Liquid Crystal Display Technology with Dual Cell Design. SID Symposium Digest of Technical Papers. 2026;57(S1):524-526. doi:10.1002/sdtp.70003_135
BibTeX
@article{Liu2026,
author = {Liu, Tao and Liu, Xianhe and Zhang, Xiang and Jiang, Jun and Zheng, Huilong and Liao, Peter and Chung, Smart},
title = {52‐4: A Four‐Way Viewing Angle Controllable Liquid Crystal Display Technology with Dual Cell Design},
journal = {SID Symposium Digest of Technical Papers},
year = {2026},
volume = {57},
number = {S1},
pages = {524--526},
doi = {10.1002/sdtp.70003_135}
}
EUVIMED